Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Covington
UBS
Cipla
Merck
Boehringer Ingelheim
McKinsey
Accenture
Teva
Cerilliant
McKesson

Generated: February 19, 2018

DrugPatentWatch Database Preview

Details for Patent: 5,145,684

« Back to Dashboard

Summary for Patent: 5,145,684
Title: Surface modified drug nanoparticles
Abstract:Dispersible particles consisting essentially of a crystalline drug substance having a surface modifier adsorbed on the surface thereof in an amount sufficient to maintain an effective average particle size of less than about 400 nm, methods for the preparation of such particles and dispersions containing the particles. Pharmaceutical compositions containing the particles exhibit unexpected bioavailability and are useful in methods of treating mammals.
Inventor(s): Liversidge; Gary G. (West Chester, PA), Cundy; Kenneth C. (Pottstown, PA), Bishop; John F. (Rochester, NY), Czekai; David A. (Honeoye Falls, NY)
Assignee: Sterling Drug Inc. (New York, NY)
Application Number:07/647,105
Patent Claim Types:
see list of patent claims
Compound; Composition; Use;

Drugs Protected by US Patent 5,145,684

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Patent Submitted
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Patent Submitted

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

International Patents Family Members for US Patent 5,145,684

Country Document Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
Austria 150297 ➤ Sign Up
Austria 184202 ➤ Sign Up
Austria 190835 ➤ Sign Up
Austria 195416 ➤ Sign Up
Australia 1014592 ➤ Sign Up
Australia 1014792 ➤ Sign Up
Australia 4156093 ➤ Sign Up
Australia 4396493 ➤ Sign Up
Australia 642066 ➤ Sign Up
Australia 654836 ➤ Sign Up
Country Document Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Colorcon
Cantor Fitzgerald
AstraZeneca
Citi
Cerilliant
Healthtrust
Farmers Insurance
Johnson and Johnson
Argus Health

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot